Subscribe to RSS
DOI: 10.1055/s-0030-1258167
Enantioselective Total Synthesis of (R)-α-Lipoic Acid: An Application of Thermodynamically Controlled Deracemization of (±)-2-(2-Methoxyethyl)cyclohexanone
Publication History
Publication Date:
12 July 2010 (online)
Abstract
According to the concept of thermodynamically controlled deracemization, racemic 2-(2-methoxyethyl)cyclohexanone was converted into the R-isomer (99% ee) in 90% yield using (-)-(2R,3R)-trans-2,3-bis(hydroxydiphenylmethyl)-1,4-dioxaspiro[5.4]decane as a host molecule under basic conditions. As an application, a short and enantioselective synthesis of (R)-α-lipoic acid was accomplished in 44% overall yield from (±)-2-(2-methoxyethyl)cyclohexanone.
Key words
(R)-α-lipoic acid - deracemization - molecular recognition - host-guest systems - asymmetric synthesis
(R)-α-Lipoic acid (1) (Figure [¹] ), which was isolated as a growth-promoting enzyme cofactor, [¹] plays an important role as a protein-bound transacylating cofactor of several multi-enzymatic α-keto acid dehydrogenase complexes. Since its discovery, (R)-α-lipoic acid (1) has attracted great attention because of its fascinating biological activity. For example, it shows effects in diabetes mellitus [²] and hepatic diseases. [³] It has also been reported that 1 and its derivatives are highly active as anti-HIV [4] and antitumor agents. [5]

Figure 1 (R)-α-Lipoic acid (1)
Lipoic acid is often used in its racemic form for therapy purposes because the S-enantiomer shows no significant biological side effects. However, the enantioselective synthesis of the R-enantiomer 1 has attracted a great deal of interest among organic and medicinal chemists. For example, the synthesis has been achieved by using of ‘chiral pool’ starting materials, [6] baker’s yeast reductions, [7] asymmetric allylation, [8] asymmetric dihydroxylation/hydrogenation, [9] Sharpless asymmetric epoxidation, [¹0] and so on. [¹¹]
Recently, we developed thermodynamically controlled deracemization of racemic α-monosubstituted cycloalkanones utilizing a chiral host molecule under basic suspension media. [¹²] For example, the use of (-)-(2R,3R)-trans-2,3-bis(hydroxydiphenylmethyl)-1,4-dioxaspiro[5.4]decane (2a) [¹³] (1.0-2.0 equiv) or (4R,5R)-α,α,α′,α′,2-pentaphenyl-1,3-dioxolane-4,5-dimethanol (2b) [¹³] as host molecules with sodium hydroxide in aqueous methanol converted racemic 2-allylcyclohexanone [(±)-3] and 2-(2-methoxyethyl)cyclohexanone [(±)-4] into their R-isomers with 74% ee and 94% ee, respectively, in quantitative yields (Scheme [¹] ).

Scheme 1 Thermodynamically controlled deracemization using TADDOL-type host molecules
In the course of our detailed investigations on deracemization, we found that the proportion of water in aqueous methanol influenced the enantiomeric purity of the ketone (R)-3. [¹4] Based on this finding, we succeeded in obtaining (R)-3 with 93% ee in 70% yield, when the recovery of 3 was sacrificed to some extent by filtration. We then synthesized (-)-(R)-epilachnene, an antipode of the defensive droplets from the Mexican bean beetle Epilachna varivestis, in a few steps using (R)-3 as the starting material.
As another application of the deracemization, we have successfully accomplished an enantioselective total synthesis of (R)-α-lipoic acid (1) starting from (±)-4 in five steps (Scheme [²] ). Here, we report the results in detail.

Scheme 2 Deracemization of (±)-4
We reported previously that 250 mg of (±)-4 was converted into the R-isomer (94% ee) in 96% yield using 2a (2 equiv) with sodium hydroxide (4 equiv) in a mixture of water-methanol (2:1) (vide supra) after stirring for two days. [¹²c] However, a prolonged reaction time (7 d) was required for a 500-mg scale deracemization. To reproduce the 250-mg scale result, the period of reaction had to be extended up to one week. Then, optical resolution by inclusion complexation was carried out to remove the unfavorable enantiomer (S-isomer) of 4. This was accomplished by mixing the obtained (R)-4 again with 2a (2 equiv) in a fresh mixture of water-methanol (2:1) without base for one day. After filtration, a solid residue was recovered and subjected to silica gel column chromatography to afford (R)-4 with 99% ee in 90% yield from (±)-4 (Scheme [³] ), and host molecule 2a (>99%) that was reusable after recrystallization. In contrast, (R)-4 with 5.9% ee was recovered in 9.0% yield from the filtrate.

Scheme 3 A 500-mg scale of deracemization of 4
The R-isomer (R)-4 was subjected to Baeyer-Villiger oxidation using 3-chloroperoxybenzoic acid with anhydrous sodium dihydrogen phosphate to afford lactone 5 in 93% yield (Scheme [4] ). Treatment of 5 with diiodosilane [¹5] cleaved the methyl ether linkage with concomitant ring-opening iodination of the lactone via a SN2-type mechanism at C6. Without further purification, the resulting primary alcohol 6 was subsequently converted into mesylate 7. The final step was achieved by treating 7 with a mixture of sodium sulfide and sulfur in N,N-dimethylformamide at 80 ˚C without protection of the carboxylic acid. Silica gel column chromatography of the resulting mixture gave 1 in 79% yield [mp 43-45 ˚C (pentane), [α]D ¹9 +112 (c 0.24, benzene)], whose physical properties compared well with those in the literature [¹6] [mp 46-48 ˚C, [α]D ²5 +104 (c 0.88, benzene)]. Thus, (R)-α-lipoic acid (1) was synthesized quite satisfactorily in five steps (44% overall yield) starting from (±)-2-(2-methoxyethyl)cyclohexanone [(±)-4].

Scheme 4 Total synthesis of (R)-α-lipoic acid
The deracemization of (±)-2-(2-methoxyethyl)cyclohexanone [(±)-4] was accomplished utilizing (-)-(2R,3R)-trans-2,3-bis(hydroxydiphenylmethyl)-1,4-dioxaspiro[5.4]decane (2a) as a host molecule to afford (R)-4, which was employed as a starting material for the total synthesis of (R)-α-lipoic acid (1).
This illustrates that thermodynamically controlled deracemization could provide a convenient and excellent method for the preparation of optically active α-mono-substituted cyclohexanones. Further studies to disclose the principle of the molecular recognition process and the applicability of the present method are now in progress.
Melting points were determined on a Yanaco MP-3 apparatus and are uncorrected. IR spectra were recorded from either neat liquid films or solids in KBr pellets on a Jasco Model FT/IR-410 spectrophotometer. ¹H NMR spectra were recorded on a Varian Gemini 200 (200 MHz), Varian Unity 200 (200 MHz), Varian Mercury 300 (300 MHz), or Varian 400 MR (400 MHz) spectrometer in CDCl3 relative to internal TMS. ¹³C NMR spectra were taken on a Varian 400 MR (100 MHz) and chemical shifts were referenced to the residual solvent signal (CDCl3: δ = 76.9). Mass spectra including HRMS were recorded on a Jeol AX-500 spectrometer.
Optional rotations were measured on a Jasco DIP-1000 polarimeter using a 10-cm microcell. Capillary gas chromatographic analyses were performed on a Shimadzu GC-14A gas chromatograph equipped with 30 m × 0.25 mm fused-silica α-DEX120 and β-DEX325 SUPELCO columns. Helium was used as the carrier gas and peak area integrations were uncorrected for flame ionization detector response. Analytical HPLC was performed on a Jasco system consisting of a pump (PU-980) and a photodiode array detector (UV-970, set at 330 nm) and equipped with a Daicel Chiracel OJ or OD column. Peak areas were measured by electronic integration on a Shimadzu C-R7Aplus chromatopac.
In general, reagent grade solvents were used. DMF was distilled from CaH2 under reduced pressure. CH2Cl2 and Et3N were distilled from CaH2 under an argon atmosphere. Analytical TLC was performed on precoated silica gel 60 F-254 plates (0.2-mm layers) on glass with fluorescent indicator, supplied by E. Merck. For column chromatography, Fuji silysia BW-127ZH (53-150 µm) or BW-300 (32-53 µm) was used.
Deracemization of (±)-2-(2-Methoxyethyl)cyclohexanone (4); Preparation of ( R )-4
To a soln of (±)-4 (500 mg, 3.20 mmol) [¹7] in MeOH (16.7 mL) was added host compound 2a (3.25 g, 6.41 mmol, 2 equiv), then distilled H2O (20.5 mL) and aq 1 M NaOH (12.8 mL, 4 equiv) were added. The resulting mixture was stirred vigorously at r.t. for 7 d and then it was poured into sat. aq NH4Cl soln (100 mL) and extracted with Et2O (3 × 100 mL). After evaporation of the ethereal solns in vacuo, the residue was chromatographed (silica gel, 200 g, toluene-Et2O to hexane-Et2O) to afford ketone (R)-4 (503 mg, >99%, 92% ee) as a colorless oil and 2a (3.31 g, >99%). The obtained (R)-4 was mixed again with fresh host 2a (3.25 g, 2 equiv) in 33% aq MeOH (50 mL) without base. After vigorous stirring at r.t. for 1 d, the resulting mixture was filtered and the residue was washed with H2O-MeOH (2:1, 3 × 5 mL). The residue was subjected to column chromatography (silica gel, 200 g, toluene-Et2O to hexane-Et2O) to afford (R)-4; yield: 90% [from (±)-4]; 99% ee [GLC (chiral column, SUPELCO, α-DEX120, 110 ˚C): t R = 24.6 min]; R f = 0.36 (hexane-EtOAc, 3:1).
[α]D ²¹ +0.82 (c 1.00, CHCl3) [Lit. [¹8] [α]D +0.38 (c 9, CHCl3)].
¹H NMR (400 MHz, CDCl3): δ = 3.43 (ddd, J = 9.4, 6.5, 5.9 Hz, 1 H, H2′a), 3.39 (ddd, J = 9.4, 6.9, 5.9 Hz, 1 H, H2′b), 3.31 (s, 3 H, CH3), 2.53-2.45 (m, 1 H), 2.44-2.36 (m, 1 H), 2.36-2.27 (m, 1 H), 2.18-2.10 (m, 2 H), 2.10-2.02 (m, 1 H), 1.90-1.81 (m, 1 H), 1.75-1.60 (m, 2 H), 1.45-1.33 (m, 2 H).
¹³C NMR (100 MHz, CDCl3): δ = 213.0, 70.3, 58.4, 47.1, 42.1, 34.2, 29.3, 28.0, 25.0.
( R )-7-(2-Methoxyethyl)oxepan-2-one (5)
To a mixture of (R)-4 (660 mg, 4.22 mmol) and NaH2PO4 (1.53 g, 12.7 mmol) in CH2Cl2 (40 mL) was added MCPBA (1.56 g, 6.33 mmol, 1.5 equiv). The mixture was stirred at r.t. for 6 h and then filtered through Celite. The filtrate was diluted with CH2Cl2 (50 mL) and washed with sat. aq Na2S2O3 (150 mL), sat. aq NaHCO3 (150 mL), and sat. aq NaCl (100 mL). The organic layer was dried (MgSO4), filtered, and concentrated. Purification of the residue by column chromatography (silica gel, 27 g, hexane-Et2O, 3:1) yielded 5 (683 mg, 93%) as a colorless oil; R f = 0.35 (hexane-EtOAc, 3:1).
[α]D ²5 -63.3 (c 1.00, CHCl3).
IR (neat): 1729 cm-¹ (C=O).
¹H NMR (400 MHz, CDCl3): δ = 4.45 (td, J = 8.8, 4.3 Hz, 1 H, H7), 3.56 (ddd, J = 9.4, 8.8, 4.5 Hz, 1 H, H9a), 3.45 (dt, J = 9.6, 5.1 Hz, 1 H, H9b), 3.34 (s, 3 H, CH3), 2.72-2.59 (m, 2 H, H3), 1.99-1.88 (m, 4 H), 1.80 (dddd, J = 14.3, 8.8, 5.3, 3.9 Hz, 1 H), 1.70-1.56 (m, 3 H).
¹³C NMR (100 MHz, CDCl3): δ = 175.7, 76.9, 68.2, 58.7, 36.4, 34.8, 34.6, 28.1, 22.9.
MS (CI): m/z = 173 ([M + H]+, base peak), 155, 141, 123, 81.
HRMS (CI): m/z [M + H]+ calcd for C9H17O3: 173.1178; found: 173.1174.
( S )-6-Iodo-8-(methylsulfonyloxy)octanoic Acid (7)
A soln of SiH2I2 (300 µL, 2.99 mmol) in anhyd CH2Cl2 (4 mL) was added to a soln of lactone 5 (101 mg, 0.585 mmol) in anhyd CH2Cl2 (3 mL) under an argon atmosphere and the mixture was stirred at 50 ˚C for 1 d. The resulting mixture was quenched with sat. aq NaHCO3 soln (20 mL) and sat. aq Na2CO3 (40 mL) and washed with CH2Cl2 (3 × 50 mL). After acidification of the aqueous layer with 6 M HCl soln (pH 1) followed by addition of NaCl, the mixture was extracted with CH2Cl2 (5 × 100 mL). The combined organic layers were dried (MgSO4), filtered, and concentrated to afford unpurified (S)-8-hydroxy-6-iodooctanoic acid (6) (153 mg).
To a soln of crude 6 in anhyd CH2Cl2 (5 mL) was added Et3N (405 µL, 2.91 mmol) and MsCl (200 µL, 2.58 mmol) at -30 ˚C and the mixture was stirred for 10 min. 2 M HCl (15 mL) was added followed by extraction with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4), filtered, and concentrated. Purification of the residue by column chromatography (silica gel, 6 g, hexane-EtOAc, 5:1 to 3:1, 2:1, and 1:1) yielded 7 (134 mg, 67%) as a colorless oil; R f = 0.38 (hexane-EtOAc, 1:3).
[α]D ²² +12.2 (c 1.00, CHCl3).
IR (neat): 2938 (OH), 1708 cm-¹ (C=O).
¹H NMR (400 MHz, CDCl3): δ = 10.9 (br s, 1 H, COOH), 4.45 (dt, J = 10.2, 5.1 Hz, 1 H, H8a), 4.40-4.32 (m, 1 H, H8b), 4.21-4.13 (m, 1 H, H6), 3.06 (s, 3 H, CH3), 2.40 (t, J = 7.3 Hz, 2 H, H2), 2.20-2.13 (m, 2 H, H7), 1.98-1.87 (m, 1 H, H5a), 1.84-1.73 (m, 1 H, H5b), 1.73-1.56 (m, 3 H, H3, H4a), 1.56-1.43 (m, 1 H, H4b).
¹³C NMR (100 MHz, CDCl3): δ = 178.6, 69.6, 40.0, 39.3, 37.3, 33.4, 32.0, 28.7, 23.6.
MS (CI): m/z = 365 [M + H]+, 347 (base peak), 269, 237, 219, 123.
HRMS (CI): m/z [M + H]+ calcd for C9H18IO5S: 364.9920; found: 364.9918.
( R )-α-Lipoic Acid (1)
Na2S˙9 H2O (76.8 mg, 0.320 mmol) and sulfur (10.4 mg, 0.325 mmol) were stirred in anhyd DMF (8 mL) at 80 ˚C for 1 h under an argon atmosphere in the dark and then a soln of 7 (102 mg, 0.279 mmol) in anhyd DMF (4 mL) was added to the mixture. The mixture was stirred at 80 ˚C for 2 h, distilled H2O (20 mL) and 2 M HCl (2 mL) were added, and the resulting mixture was extracted with Et2O (3 × 40 mL). The combined organic layers were dried (MgSO4), filtered, and concentrated. Purification of the residue by column chromatography (silica gel, 10 g, hexane-Et2O, 5:1 to 3:1) yielded 1 (46 mg, 79%, 93% ee) as a yellow solid. Recrystallization (pentane) gave 1; 99% ee [HPLC (chiral column, Daicel, Chiralcel OD; hexane-i-PrOH-TFA, 99:1:0.05; UV 330 nm), t R = 29.9 min]; mp 43-45 ˚C (pentane) (Lit. [¹6] 46-48 ˚C); R f = 0.37 (hexane-EtOAc, 1:1).
[α]D ¹9 +112.2 (c 0.24, benzene) [Lit. [¹6] [α]D ²5 +104 (c 0.88, benzene)].
IR (KBr): 3040 (OH), 1705 cm-¹ (C=O).
¹H NMR (400 MHz, CDCl3): δ = 10.6 (br s, 1 H, COOH), 3.58 (dtd, J = 8.3, 6.4, 6.3 Hz, 1 H, H6), 3.19 (dddd, J = 11.0, 7.0, 5.3, 0.3 Hz, 1 H, H8a), 3.12 (dt, J = 11.0, 6.9 Hz, 1 H, H8b), 2.47 (dtd, J = 11.9, 6.6, 5.4 Hz, 1 H, H7a), 2.38 (t, J = 7.3 Hz, 2 H, H2), 1.92 (dtd, J = 12.8, 7.0, 6.9 Hz, 1 H, H7b), 1.78-1.61 (m, 4 H, 2 CH2), 1.59-1.41 (m, 2 H, CH2).
¹³C NMR (100 MHz, CDCl3): δ = 178.3, 56.2, 40.1, 38.4, 34.5, 33.4, 28.6, 24.3.
MS (EI): m/z = 206 (M+, base peak), 173, 149, 105, 123, 95.
HRMS (EI): m/z [M]+ calcd for C8H14O2S2: 206.0435; found: 206.0433.
Acknowledgment
This work was supported in part by a Grant-in-Aid for Scientific Research (C, 19590028) from MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan). We are also thankful to MEXT.HAITEKU, 2003-2007.
- 1
Reed LJ.DeBusk BG.Gunsalus IC.Hornberger CS. Science 1951, 114: 93 - 2
Jacob S.Ruus P.Hermann R.Tritschler HJ.Maerker E.Renn W.Augustin HJ.Dietze GJ.Rett K. Free Radical Biol. Med. 1999, 27: 309 - 3
Thoelen H.Zimmerli W.Rajacic Z. Experientia 1985, 41: 1042 - 4
Baur A.Harrer T.Peukert M.Jahn G.Kalden JR.Fleckenstein B. Klin. Wocheschr. 1991, 69: 722 ; Chem. Abstr. 1992, 116, 207360. - 5
Bingham PM, andZachar Z. inventors; WO 0,024,734. ; Chem. Abstr. 2000, 132, 308192. - 6a
Tolstikov AG.Khakhalina NV.Savateeva EE.Spirikhin LV.Khalilov LM.Odinokov VN.Tolstikov GA. Bioorg. Khim. 1990, 16: 1670 - 6b
Yadav JS.Mysorekar SV.Pawar SM.Gurjar MK.
J. Carbohydr. Chem. 1990, 9: 307 - 6c
Brookes MH.Golding BT. J. Chem. Soc., Perkin Trans. 1 1988, 9 - 6d
Rama Rao AV.Gurjar MK.Garyali K.Ravindranathan T. Carbohydr. Res. 1986, 148: 51 - 6e
Brookes MH.Golding BT.Howes DA.Hudson AT. J. Chem. Soc., Chem. Commun. 1983, 1051 - 7a
Dasaradhi L.Fadnavis NW.Bhalerao UT. J. Chem. Soc., Chem. Commun. 1990, 729 - 7b
Gopalan AS.Jacobs HK. J. Chem. Soc., Perkin Trans. 1 1990, 1897 - 8
Zimmer R.Hain U.Berndt M.Gewald R.Reissig H.-U. Tetrahedron: Asymmetry 2000, 11: 879 - 9
Upadhya TT.Nikalje MD.Sudalai A. Tetrahedron Lett. 2001, 42: 4891 - 10a
Page PCB.Rayner CM.Sutherland IO. J. Chem. Soc., Perkin Trans. 1 1990, 1615 - 10b
Page PCB.Rayner CM.Sutherland IO. J. Chem. Soc., Chem. Commun. 1986, 1408 - 11a
Bose DS.Fatina L.Rajender S. Synthesis 2006, 1863 - 11b
Chavan SP.Praveen C.Ramakrishna G.Kalkote UR. Tetrahedron Lett. 2004, 45: 6027 - 11c
Zimmer R.Peritz A.Czerwonka R.Schefzig L.Reißig H.-U. Eur. J. Org. Chem. 2002, 3419 - 11d
Ganaha M.Yamauchi S.Kinoshita Y. Biosci. Biotechnol. Biochem. 1999, 63: 2025 - 11e
Bringmann G.Herzberg D.Adam G.Balkenhohl F.Paust J. Z. Naturforsch., B: Chem. Sci. 1999, 54b: 655 - 11f
Adger B.Bes MT.Grogan G.McCague R.Pedragosa-Moreau S.Roberts SM.Villa R.Wan PWH.Willetts AJ. Bioorg. Med. Chem. 1997, 5: 253 - 11g
Bezbarua M.Saikia AK.Barua NC.Kalita D.Ghosh AC. Synthesis 1996, 1289 - 11h
Laxmi YRS.Iyengar DS. Synthesis 1996, 594 - 11i
Adger B.Bes MT.Grogan G.McCague R.Pedragosa-Moreau S.Roberts SM.Villa R.Wan PWH.Willetts AJ. J. Chem. Soc., Chem. Commun. 1995, 1563 - 11j
Menon RB.Kumar MA.Ravindranathan T. Tetrahedron Lett. 1987, 28: 5313 - 11k
Rama Rao AV.Purandare AV.Reddy ER.Gurjar MK. Synth. Commun. 1987, 17: 1095 - 11l
Rama Rao AV.Mysorekar SV.Gurjar MK.Yadav JS. Tetrahedron Lett. 1987, 28: 2183 - 11m
Elliott JD.Steele J.Johnson WS. Tetrahedron Lett. 1985, 26: 2535 - 12a
Kaku H.Takaoka S.Tsunoda T. Tetrahedron 2002, 58: 3401 - 12b
Kaku H.Ozako S.Kawamura S.Takatsu S.Ishii M.Tsunoda T. Heterocycles 2001, 55: 847 - 12c
Tsunoda T.Kaku H.Nagaku M.Okuyama E. Tetrahedron Lett. 1997, 38: 7759 - 13
Seebach D.Beck AK.Imwinkelried R.Roggo S.Wonnacott A. Helv. Chim. Acta 1987, 70: 954 - 14
Kaku H.Okamoto N.Nakamaru A.Tsunoda T. Chem. Lett. 2004, 33: 516 - 15
Keinan E.Sahai M. J. Org. Chem. 1990, 55: 3922 - 16
Merck Index
12th
ed.:
Budavari S.O’Neil MJ.Smith A.Heckelman PE.Kinneary JF. Merck & Co., Inc.; Whitehouse Station NJ: 1996. 1591. p.No. 9462 - 17
Dotani M. inventors; JP 2007,297,352 A. ; Chem. Abstr. 2007, 147: 521898. - 18
Meyers AI.Williams DR.Erickson GW.White S.Druelinger M. J. Am. Chem. Soc. 1981, 103: 3081
References
- 1
Reed LJ.DeBusk BG.Gunsalus IC.Hornberger CS. Science 1951, 114: 93 - 2
Jacob S.Ruus P.Hermann R.Tritschler HJ.Maerker E.Renn W.Augustin HJ.Dietze GJ.Rett K. Free Radical Biol. Med. 1999, 27: 309 - 3
Thoelen H.Zimmerli W.Rajacic Z. Experientia 1985, 41: 1042 - 4
Baur A.Harrer T.Peukert M.Jahn G.Kalden JR.Fleckenstein B. Klin. Wocheschr. 1991, 69: 722 ; Chem. Abstr. 1992, 116, 207360. - 5
Bingham PM, andZachar Z. inventors; WO 0,024,734. ; Chem. Abstr. 2000, 132, 308192. - 6a
Tolstikov AG.Khakhalina NV.Savateeva EE.Spirikhin LV.Khalilov LM.Odinokov VN.Tolstikov GA. Bioorg. Khim. 1990, 16: 1670 - 6b
Yadav JS.Mysorekar SV.Pawar SM.Gurjar MK.
J. Carbohydr. Chem. 1990, 9: 307 - 6c
Brookes MH.Golding BT. J. Chem. Soc., Perkin Trans. 1 1988, 9 - 6d
Rama Rao AV.Gurjar MK.Garyali K.Ravindranathan T. Carbohydr. Res. 1986, 148: 51 - 6e
Brookes MH.Golding BT.Howes DA.Hudson AT. J. Chem. Soc., Chem. Commun. 1983, 1051 - 7a
Dasaradhi L.Fadnavis NW.Bhalerao UT. J. Chem. Soc., Chem. Commun. 1990, 729 - 7b
Gopalan AS.Jacobs HK. J. Chem. Soc., Perkin Trans. 1 1990, 1897 - 8
Zimmer R.Hain U.Berndt M.Gewald R.Reissig H.-U. Tetrahedron: Asymmetry 2000, 11: 879 - 9
Upadhya TT.Nikalje MD.Sudalai A. Tetrahedron Lett. 2001, 42: 4891 - 10a
Page PCB.Rayner CM.Sutherland IO. J. Chem. Soc., Perkin Trans. 1 1990, 1615 - 10b
Page PCB.Rayner CM.Sutherland IO. J. Chem. Soc., Chem. Commun. 1986, 1408 - 11a
Bose DS.Fatina L.Rajender S. Synthesis 2006, 1863 - 11b
Chavan SP.Praveen C.Ramakrishna G.Kalkote UR. Tetrahedron Lett. 2004, 45: 6027 - 11c
Zimmer R.Peritz A.Czerwonka R.Schefzig L.Reißig H.-U. Eur. J. Org. Chem. 2002, 3419 - 11d
Ganaha M.Yamauchi S.Kinoshita Y. Biosci. Biotechnol. Biochem. 1999, 63: 2025 - 11e
Bringmann G.Herzberg D.Adam G.Balkenhohl F.Paust J. Z. Naturforsch., B: Chem. Sci. 1999, 54b: 655 - 11f
Adger B.Bes MT.Grogan G.McCague R.Pedragosa-Moreau S.Roberts SM.Villa R.Wan PWH.Willetts AJ. Bioorg. Med. Chem. 1997, 5: 253 - 11g
Bezbarua M.Saikia AK.Barua NC.Kalita D.Ghosh AC. Synthesis 1996, 1289 - 11h
Laxmi YRS.Iyengar DS. Synthesis 1996, 594 - 11i
Adger B.Bes MT.Grogan G.McCague R.Pedragosa-Moreau S.Roberts SM.Villa R.Wan PWH.Willetts AJ. J. Chem. Soc., Chem. Commun. 1995, 1563 - 11j
Menon RB.Kumar MA.Ravindranathan T. Tetrahedron Lett. 1987, 28: 5313 - 11k
Rama Rao AV.Purandare AV.Reddy ER.Gurjar MK. Synth. Commun. 1987, 17: 1095 - 11l
Rama Rao AV.Mysorekar SV.Gurjar MK.Yadav JS. Tetrahedron Lett. 1987, 28: 2183 - 11m
Elliott JD.Steele J.Johnson WS. Tetrahedron Lett. 1985, 26: 2535 - 12a
Kaku H.Takaoka S.Tsunoda T. Tetrahedron 2002, 58: 3401 - 12b
Kaku H.Ozako S.Kawamura S.Takatsu S.Ishii M.Tsunoda T. Heterocycles 2001, 55: 847 - 12c
Tsunoda T.Kaku H.Nagaku M.Okuyama E. Tetrahedron Lett. 1997, 38: 7759 - 13
Seebach D.Beck AK.Imwinkelried R.Roggo S.Wonnacott A. Helv. Chim. Acta 1987, 70: 954 - 14
Kaku H.Okamoto N.Nakamaru A.Tsunoda T. Chem. Lett. 2004, 33: 516 - 15
Keinan E.Sahai M. J. Org. Chem. 1990, 55: 3922 - 16
Merck Index
12th
ed.:
Budavari S.O’Neil MJ.Smith A.Heckelman PE.Kinneary JF. Merck & Co., Inc.; Whitehouse Station NJ: 1996. 1591. p.No. 9462 - 17
Dotani M. inventors; JP 2007,297,352 A. ; Chem. Abstr. 2007, 147: 521898. - 18
Meyers AI.Williams DR.Erickson GW.White S.Druelinger M. J. Am. Chem. Soc. 1981, 103: 3081
References

Figure 1 (R)-α-Lipoic acid (1)

Scheme 1 Thermodynamically controlled deracemization using TADDOL-type host molecules

Scheme 2 Deracemization of (±)-4

Scheme 3 A 500-mg scale of deracemization of 4

Scheme 4 Total synthesis of (R)-α-lipoic acid